Chao-Wei Liao

Title: Innovations of Chao-Wei Liao in HIV Research

Introduction

Chao-Wei Liao is a prominent inventor based in Shin-Chu, Taiwan, known for his significant contributions to the field of HIV research. With a total of five patents to his name, Liao has developed innovative methods aimed at inducing immune responses against HIV.

Latest Patents

Liao's latest patents include groundbreaking work on chimeric HIV fusion proteins as vaccines. One of his notable inventions discloses a method for inducing HIV antigen-specific immune responses. This method involves administering a therapeutically effective amount of a chimeric fusion protein that comprises a first polypeptidyl region with a binding domain and a translocation domain, along with a second polypeptidyl region featuring a fusion peptide of HIV gp120-C1-C5-gp41. Additionally, he has developed a method for inducing neutralizing antibodies against HIV-1. Another patent focuses on fusion antigens used as vaccines, detailing a method that includes selecting a segment of a virus protein sequence containing at least one epitope, engineering a DNA fragment encoding this segment, and expressing it in a host cell to obtain a chimeric vaccinal virus antigen.

Career Highlights

Throughout his career, Chao-Wei Liao has worked with notable organizations such as the Animal Technology Institute Taiwan and Healthbanks Biotech Co., Ltd. His work has been instrumental in advancing the understanding and treatment of HIV.

Collaborations

Liao has collaborated with esteemed colleagues, including Hsiu-Kang Chang and Chung-Nan Weng, contributing to the collective effort in HIV research and vaccine development.

Conclusion

Chao-Wei Liao's innovative work in the field of HIV research has led to significant advancements in vaccine development. His contributions continue to play a crucial role in the fight against HIV, showcasing the importance of innovation in medical science.